Triple
T667631
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | European Directorate for the Quality of Medicines & HealthCare |
E12899
|
entity |
| Predicate | cooperatesWith |
P435
|
FINISHED |
| Object | European Medicines Agency |
E3950
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Medicines Agency | Statement: [European Directorate for the Quality of Medicines & HealthCare, cooperatesWith, European Medicines Agency]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: European Medicines Agency Context triple: [European Directorate for the Quality of Medicines & HealthCare, cooperatesWith, European Medicines Agency]
-
A.
European Medicines Agency
chosen
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
Committee for Herbal Medicinal Products
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
-
D.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
E.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a493355dec819098d4244b2fa34885 |
completed | March 1, 2026, 7:27 p.m. |
| NER | Named-entity recognition | batch_69a49ff921288190a2e5edb201ba69ee |
completed | March 1, 2026, 8:22 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a6374a189c81908f7bc0828e9ff382 |
completed | March 3, 2026, 1:20 a.m. |
Created at: March 1, 2026, 7:36 p.m.